FAVUS ELLIOT 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed May 25, 2021
Insider Transaction Report
Form 4
FAVUS ELLIOT
Director
Transactions
- Exercise/Conversion
Common Stock
2021-05-21$2.96/sh+50,000$148,000→ 145,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−50,000→ 0 totalExercise: $0.92From: 2015-04-02Exp: 2025-04-02→ Common Stock (50,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−1,500→ 0 totalExercise: $5.57From: 2015-12-31Exp: 2025-12-31→ Common Stock (1,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−1,500→ 0 totalExercise: $5.66From: 2016-04-27Exp: 2026-04-27→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2021-05-21$0.92/sh+50,000$46,000→ 87,500 total - Sale
Common Stock
2021-05-21$11.70/sh−145,000$1,696,283→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−1,500→ 0 totalExercise: $5.64From: 2015-12-31Exp: 2025-09-30→ Common Stock (1,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−1,500→ 0 totalExercise: $4.90From: 2016-03-31Exp: 2026-03-31→ Common Stock (1,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−1,500→ 0 totalExercise: $6.11From: 2016-06-30Exp: 2026-06-30→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2021-05-21$1.20/sh+37,500$45,000→ 37,500 total - Exercise/Conversion
Common Stock
2021-05-21$5.57/sh+1,500$8,355→ 90,500 total - Exercise/Conversion
Common Stock
2021-05-21$6.11/sh+1,500$9,165→ 95,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−50,000→ 0 totalExercise: $2.96From: 2021-01-06Exp: 2030-01-06→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2021-05-21$5.64/sh+1,500$8,460→ 89,000 total - Exercise/Conversion
Common Stock
2021-05-21$4.90/sh+1,500$7,350→ 92,000 total - Exercise/Conversion
Common Stock
2021-05-21$5.66/sh+1,500$8,490→ 93,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−37,500→ 0 totalExercise: $1.20From: 2015-05-07Exp: 2024-05-07→ Common Stock (37,500 underlying)